SETD2 and chronic myelogenous leukemia, BCR-ABL1 positive: To explore whether SETD2/H3K36me3 deficiency can be traced back to diagnosis, we used WB to assess SETD2 levels in matched samples collected at diagnosis and after disease progression from five CML patients.